SCHEMBL30427342

SCHEMBL30427342

CCOc1ccn2cc(C)nc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
ALDH1A1 P00352 4/20 0.43
PKM P14618 3/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
POLB P06746 2/20 0.43
MAPK1 P28482 1/20 0.43
HDAC1 Q13547 1/20 0.42
MAPT P10636 2/20 0.41
GAA P10253 1/20 0.40
TDP1 Q9NUW8 2/20 0.39
KMT2A Q03164 2/20 0.38
HRH3 Q9Y5N1 1/20 0.38
TSHR P16473 3/20 0.38
HSD17B10 Q99714 3/20 0.38
TP53 P04637 2/20 0.38
CYP3A4 P08684 1/20 0.38
CYP1A2 P05177 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7975599 0.81 KDM4E (0.51) KDM4ESMN1; SMN2ALDH1A1PKMNPC1
SCHEMBL20049567 0.81 MCHR1 (0.54) NPC1RAB9AKMT2AHRH3CYP3A4
SCHEMBL29372575 0.79 PDE10A (0.45) KDM4ESMN1; SMN2ALDH1A1PKMNPC1
SCHEMBL31119524 0.78 SCN9A (0.46) KDM4EPKMNPC1RAB9APOLB
SCHEMBL15004635 0.76 HDAC1 (0.41) KDM4ESMN1; SMN2ALDH1A1PKMNPC1
SCHEMBL24760172 0.75 NPC1 (0.53) KDM4ESMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL30259235 0.75 IRAK4 (0.45) KDM4ESMN1; SMN2ALDH1A1PKMNPC1
SCHEMBL12729868 0.75 KDM4E (0.50) KDM4ESMN1; SMN2ALDH1A1PKMNPC1
SCHEMBL16582016 0.75 ALDH1A1 (0.41) KDM4ESMN1; SMN2ALDH1A1PKMNPC1
SCHEMBL30259281 0.74 IRAK4 (0.46) KDM4ESMN1; SMN2ALDH1A1PKMNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4433457-A1 HETEROCYCLIC AMIDES AND METHODS OF USING THE SAME Rgenta Therapeutics, Inc. (US) 2024-09-25 EP disclosed
WO-2023092098-A1 HETEROCYCLIC AMIDES AND METHODS OF USING THE SAME RGENTA THERAPEUTICS, INC. (US) 2023-05-25 WO disclosed